Use of Glaukos iStent implantation produced 38% reduction in IOP

Glaukos announced that results of an international glaucoma study published in the Journal of Cataract and Refractive Surgery showed use of iStent Trabecular Micro-Bypass Stent during cataract surgery delivered a 38% reduction in mean intraocular pressure, or IOP, to 14.7 mmHg after five years of follow-up. 38%of eyes had undergone prior trabeculectomy and/or glaucoma laser procedures and 68% were on at least two preoperative glaucoma medications. These results were presented in part at the 2016 annual meeting of the European Society of Cataract and Refractive Surgeons and three-year outcomes of this study were published in the Journal of Cataract and Refractive Surgery in 2015.
https://thefly.com/landingPageNews.php?id=2878165